155295-47-9 Usage
General Description
1-PIVALOYL-PIPERAZINE is a chemical compound that is commonly used in the pharmaceutical industry as an intermediate or building block for the synthesis of various drugs and medications. It is a piperazine derivative with a pivaloyl group attached to the piperazine ring, which confers certain unique properties to the molecule. 1-PIVALOYL-PIPERAZINE is known for its ability to undergo various chemical reactions, making it a versatile and valuable ingredient in the production of pharmaceuticals. It is also used in research laboratories for the development of new drug candidates and has potential applications in medicinal chemistry and drug discovery. Additionally, 1-PIVALOYL-PIPERAZINE shows promise in certain medical treatments and therapies due to its specific chemical structure and properties. Overall, this compound plays an important role in drug development and research, and its potential uses continue to be explored in the pharmaceutical field.
Check Digit Verification of cas no
The CAS Registry Mumber 155295-47-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,2,9 and 5 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 155295-47:
(8*1)+(7*5)+(6*5)+(5*2)+(4*9)+(3*5)+(2*4)+(1*7)=149
149 % 10 = 9
So 155295-47-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H18N2O/c1-9(2,3)8(12)11-6-4-10-5-7-11/h10H,4-7H2,1-3H3
155295-47-9Relevant articles and documents
A triazene-based new photolabile linker in solid phase chemistry
Enders, Dieter,Rijksen, Christiaan,Bremus-K?bberling, Elke,Gillner, Arnold,K?bberling, Johannes
, p. 2839 - 2841 (2004)
An extension of the T2 linker methodology by showing its applicability as a photocleavable linker is reported. Photocleavage was carried out with 355nm UV laser irradiation (3ω Nd-YAG) in methanol/diethyl ether and is suitable for protected amino acid derivatives, as well as simple small organic molecules including resin-bound biotin. The linker is stable under a wide range of conditions with the exception of strongly acidic media.
Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
-
, (2008/06/13)
This invention provides a compound of the formula (I): and its pharmaceutically acceptable salts, wherein A1 and A2 are each halo; R1 and R2 are independently C1-4 alkyl; R3 is substituted or unsubstituted, phenyl or naphthyl; Y is heterocyclic group sele